Cochrane Abstracts
Direct oral anticoagulants versus warfarin for preventing stroke and systemic embolic events among atrial fibrillation patients with chronic kidney disease
There's more to see -- the rest of this topic is available only to subscribers.
Citation
"Direct Oral Anticoagulants Versus Warfarin for Preventing Stroke and Systemic Embolic Events Among Atrial Fibrillation Patients With Chronic Kidney Disease." Cochrane Abstracts, John Wiley & Sons, Inc, 2025. Evidence Central, evidence.unboundmedicine.com/evidence/view/Cochrane/433620/all/Direct_oral_anticoagulants_versus_warfarin_for_preventing_stroke_and_systemic_embolic_events_among_atrial_fibrillation_patients_with_chronic_kidney_disease.
Direct oral anticoagulants versus warfarin for preventing stroke and systemic embolic events among atrial fibrillation patients with chronic kidney disease. Cochrane Abstracts. John Wiley & Sons, Inc; 2025. https://evidence.unboundmedicine.com/evidence/view/Cochrane/433620/all/Direct_oral_anticoagulants_versus_warfarin_for_preventing_stroke_and_systemic_embolic_events_among_atrial_fibrillation_patients_with_chronic_kidney_disease. Accessed March 23, 2025.
Direct oral anticoagulants versus warfarin for preventing stroke and systemic embolic events among atrial fibrillation patients with chronic kidney disease. (2025). In Cochrane Abstracts. John Wiley & Sons, Inc. https://evidence.unboundmedicine.com/evidence/view/Cochrane/433620/all/Direct_oral_anticoagulants_versus_warfarin_for_preventing_stroke_and_systemic_embolic_events_among_atrial_fibrillation_patients_with_chronic_kidney_disease
Direct Oral Anticoagulants Versus Warfarin for Preventing Stroke and Systemic Embolic Events Among Atrial Fibrillation Patients With Chronic Kidney Disease [Internet]. In: Cochrane Abstracts. John Wiley & Sons, Inc; 2025. [cited 2025 March 23]. Available from: https://evidence.unboundmedicine.com/evidence/view/Cochrane/433620/all/Direct_oral_anticoagulants_versus_warfarin_for_preventing_stroke_and_systemic_embolic_events_among_atrial_fibrillation_patients_with_chronic_kidney_disease.
* Article titles in AMA citation format should be in sentence-case
TY - ELEC
T1 - Direct oral anticoagulants versus warfarin for preventing stroke and systemic embolic events among atrial fibrillation patients with chronic kidney disease
ID - 433620
BT - Cochrane Abstracts
UR - https://evidence.unboundmedicine.com/evidence/view/Cochrane/433620/all/Direct_oral_anticoagulants_versus_warfarin_for_preventing_stroke_and_systemic_embolic_events_among_atrial_fibrillation_patients_with_chronic_kidney_disease
PB - John Wiley & Sons, Inc
DB - Evidence Central
DP - Unbound Medicine
ER -
